Receptor occupancy in lumbar CSF as a measure of the antagonist activity of atenolol, metoprolol and propranolol in the CNS.
1. The antagonist activity of atenolol, metoprolol and propranolol in the CNS was estimated by determining the extent to which the drugs occupy animal beta 1- and beta 2-receptors in CSF ex vivo at the time of lumbar puncture. 2. Five CSF and plasma samples were obtained 4 h after drug intake from subjects treated for hypertension with atenolol, 100 mg once daily and five from subjects treated with metoprolol, 50 mg three times daily. Twenty-four samples were obtained 1, 2, 4 or 12 h after drug intake from subjects receiving a single 40 mg dose of propranolol. 3. The receptor occupancy in the samples was determined by adding beta 1-receptors of rabbit lung and beta 2-receptors of rat reticulocytes into the samples and labeling the receptors with a nonselective beta-adrenoceptor antagonist, (-)-[3H]-CGP-12177. 4. Atenolol and metoprolol occupied, as expected, larger fractions of beta 1- than beta 2-receptors in CSF and plasma samples. The receptor fraction occupied by atenolol in CSF was significantly (P < 0.05) lower than that occupied by metoprolol. The differences in occupancy between the drugs in plasma, however, were not statistically significant. 5. Propranolol occupied larger fractions of beta 2- than beta 1-receptors in the samples. Although propranolol concentrations in CSF were only 1/20-1/40 of those in plasma, the receptor occupancy of propranolol in CSF was similar to that in plasma.(ABSTRACT TRUNCATED AT 250 WORDS)
Kaila
T
T
Department of Clinical Pharmacology, University of Turku, Finland.
Marttila
R
R
D000317:Adrenergic alpha-Antagonists / Q000134:cerebrospinal fluid* / Q000494:pharmacology; D000328:Adult; D000818:Animals; D001262:Atenolol / Q000134:cerebrospinal fluid / Q000494:pharmacology; D002490:Central Nervous System / Q000187:drug effects*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008790:Metoprolol / Q000134:cerebrospinal fluid / Q000494:pharmacology; D008875:Middle Aged; D011412:Propanolamines / Q000494:pharmacology; D011433:Propranolol / Q000134:cerebrospinal fluid / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects*
D000317:Adrenergic alpha-Antagonists; D011412:Propanolamines; D011942:Receptors, Adrenergic, alpha; D001262:Atenolol; D011433:Propranolol; D008790:Metoprolol; C033394:CGP 12177